CompanyProfileNomu

Actions

Naba Alsaha Medical Services Co.

9546
NABA ALSAHA
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Nomu - Parallel Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close 100.00
  • Open 99.10
  • High 100.00
  • Low 98.00
  • No. Of Trades 16
  • Avg. Trade size* 145
  • Volume Traded 2,325
  • Value Traded 231,091.80

Performance

NABA ALSAHA
-1.90 ( -1.90% )
Compare
Name Price Change %
Naba Alsaha Medical Services Co. 99.10 -1.90%
Quote delayed by 5 mins
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Trade Updates

Price
98.10
% Change
-1.90
Volume Traded
50

Best Bid

Price 98.10
Volume 110

Best Offer

Price 103.00
Volume 250

52 WEEK

High
105.00
2024/06/12
Low
39.91
2023/06/14
change
145.37

PERFORMANCE

Start of Year
58.7
Year ago
39.98
3 Years ago

Compare Selected

Select A Maximum Of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Naba Alsaha Medical Services Co. Board invites its shareholders to attend the Ordinary General Assembly Meeting the (First Meeting)

    9546
    NABA ALSAHA -1.9 %
    1445/12/03     09/06/2024 08:02:24
  • Naba Alsaha Medical Services Co. Announces Calling Candidature for Board Members Elections

    9546
    NABA ALSAHA -1.9 %
    1445/10/13     22/04/2024 17:59:09
  • Naba Alsaha Medical Services Co. announces its Annual Financial results for the period ending on 2023-12-31

    9546
    NABA ALSAHA -1.9 %
    1445/09/20     30/03/2024 16:33:33
  • Naba Alsaha Medical Services Co. Announces that Al-Anwar Medical Hospital in Hail, owned by Naba Al-Saha Company, has obtained the renewal of accreditation from the Saudi Center for Accreditation of Health Facilities.

    9546
    NABA ALSAHA -1.9 %
    1445/09/07     17/03/2024 16:28:36
  • Naba Al-Saha Medical Services Company announces the opening of a branch of Naba Al-Saha Pharmacy.

    9546
    NABA ALSAHA -1.9 %
    1445/06/25     07/01/2024 09:25:54
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      29/03/2023 22/06/2023 10/07/2023 Account Transfer 0.30

      CompanyProfileNomuv2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Semi-Annual
      Balance Sheet 2023-12-31
      Total Assets
      276,718
      - - -
      Total Liabilities
      96,624
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      180,094
      - - -
      Total Liabilities and Shareholders Equity
      276,718
      - - -
      Statement of Income 2023-12-31
      Total Revenue (Sales/Operating)
      182,352
      - - -
      Net Profit (Loss) before Zakat and Tax
      54,862
      - - -
      Zakat and Income Tax
      -2,480
      - - -
      Net Profit (Loss) after Zakat and Tax
      52,382
      - - -
      Total Comprehensive Income
      52,177
      - - -
      Profit (Loss) per Share
      4.99
      - - -
      Cash Flow 2023-12-31
      Net Cash From Operating Activities
      29,358
      - - -
      Net Cash From Investing Activities
      -60,614
      - - -
      Net Cash From Financing Activities
      23,175
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      13,826
      - - -
      Cash and Cash Equivalents, End of the Period
      5,745
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2024-04-16

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet 2023-06-30
      Total Assets
      227,053
      - - -
      Total Liabilities
      71,366
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      155,687
      - - -
      Total Liabilities and Shareholders Equity
      227,053
      - - -
      Statement of Income 2023-06-30
      Total Revenue (Sales/Operating)
      81,841
      - - -
      Net Profit (Loss) before Zakat and Tax
      28,918
      - - -
      Zakat and Income Tax
      -1,149
      - - -
      Net Profit (Loss) after Zakat and Tax
      27,769
      - - -
      Total Comprehensive Income
      27,769
      - - -
      Profit (Loss) per Share
      3.97
      - - -
      Cash Flow 2023-06-30
      Net Cash From Operating Activities
      12,510
      - - -
      Net Cash From Investing Activities
      -22,674
      - - -
      Net Cash From Financing Activities
      5,133
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      13,826
      - - -
      Cash and Cash Equivalents, End of the Period
      8,795
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2024-04-16

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-06-13 نذير بن محمدحسن بن عبدالله الجشي Board of Directors 20.0642952% 20.0642952% 0
      2024-06-13 نذير بن محمدحسن بن عبدالله الجشي Senior Executives 20.0642952% 20.0642952% 0
      2024-06-13 نايف محمد حسن الجشي Board of Directors 30.0029524% 30.0029524% 0
      2024-06-13 علي احمد عبدالله الحليلي Board of Directors 0.0722667% 0.0722667% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Naba Alsaha Medical Services Co.
      Price 98.10
      Market Cap (SAR MN) 1,030
      P/E Ratio 19.66
      Index Name Index Level 1D Return
      Naba Alsaha Medical Services Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      Medical operation of medical complexes and one day surgery centers The company current activity is the operation and management of Al Zahraa Hospital Manarat Al Haramain Pharmacy, Nabea Al Saha branch for the practice of maintenance work and the operation of buildings

      Company History

      Nabaa Al Saha Medical Services Company was established on 02.25.1405 AH On 04.24.1439 The partner decision was issued to change the company name to Nabaa Al Saha Medical Services Company and the company headquarters was also changed to be in the city of Al Khobar Pursuant to Ministerial Resolution No S.122 on 23.05.1440 AH corresponding to January 29.2019 AD The company was converted from a limited liability company to a closed joint stock company while retaining the commercial registration number and date with the same capital of twenty five million Saudi riyals

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 105,000,000
      • Issued Shares 10,500,000
      • Paid Up Capital (SAR) 105,000,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2023-11-20

      Investment limits

      Risks of difficulty in recruiting health practitioners and highly qualified administrative cadres Inability to renew or amend existing contracts Risks related to the level of service quality Risks of concentrating the company revenues with revenues from the governmental and semi-governmental sectors Risks related to accounts receivable

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        2018/01/23

      • Financial Year End

        31/12

      • Listing Date

        2022/09/07

      • External Auditors

        [Maham Company For Professional Services]

      • ISIN CODE

        SA15K0SKL513

      • Number of Employees

        760

      • Chairman

        Abdulwahab Mohammed Saad Al-Ajroush
        Independent

        Abdulwahab Mohammed Saad Al-Ajroush
        • Bd Session Start
          2021-07-14
          Designation
          Chairman
        • Bd Session End
          2024-07-13
          Classification
          Independent
      • Board of Directors

        Nathir Mohamed Hassan Abdalla Aljishi Deputy Chairman - Executive

        Nathir Mohamed Hassan Abdalla Aljishi
        • Bd Session Start
          2021-07-14
          Designation
          Board of Directors
        • Bd Session End
          2023-07-13
          Classification
          Deputy Chairman - Executive

        Nayef Mohamed Hassan Abdalla Aljishi Executive

        Nayef Mohamed Hassan Abdalla Aljishi
        • Bd Session Start
          2021-07-14
          Designation
          Board of Directors
        • Bd Session End
          2024-07-13
          Classification
          Executive

        Ali Ahmed Abdalla Al-Holaily Independent

        Ali Ahmed Abdalla Al-Holaily
        • Bd Session Start
          2021-07-14
          Designation
          Board of Directors
        • Bd Session End
          2024-07-13
          Classification
          Independent

        Ahmed Saud Abdulaziz Shahini Independent

        Ahmed Saud Abdulaziz Shahini
        • Bd Session Start
          2021-07-14
          Designation
          Board of Directors
        • Bd Session End
          2024-07-13
          Classification
          Independent
      • Senior Executives

        Nathir Mohamed Hassan Abdalla Aljishi CEO

        Nathir Mohamed Hassan Abdalla Aljishi
        • Bd Session Start
          2019-04-30
          Designation
          Senior Executives
        • Bd Session End
          -
          Classification
          CEO

        Hassan Absher Habiballah Eid CFO

      Hassan Absher Habiballah Eid
      • Bd Session Start
        2020-07-15
        Designation
        Senior Executives
      • Bd Session End
        -
        Classification
        CFO

      Investor Relations

      Contact Name:

      Ahmed youssef Mohamed abdel hak

      Company Address:

      Qatif 31911 KSA P.O. Box 887

      Contact Details:

      Telephone: 966138555000+
      Fax: 966138555000+
      Email: ahmed.youssef@alzahragh.com

      Company Website:

      www.nams.sa


      Name Of Subsidiary Percentage Of Property Main Business Location Of Operation Country Of Operation
      Nabaa Al-Saha Architectural Contracting Company 100.00% General Contracting Al Khoubar KSA
      Al Zahraa general hospital 100.00% Hospitals Qatif KSA
      Manarat Al Haramain Pharmacy 100.00% pharmacies Qatif KSA
      Nabaa Al-Saha Medical Services Company 100.00% maintenance and operation Qatif KSA
      Al Anwar Medical Company 100.00% Hospitals Hail KSA
      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.